Neoadjuvant chemotherapy for bladder cancer

By Millikan R.   Siefker-Radtke A.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 464-467

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy (MVAC) in Locally Invasive Bladder Cancer

By Sagaster P.   Flamm J.   Flamm M.   Mayer A.   Donner G.   Oberleitner S.   Havelec L.   Lepsinger L.   Ludwig H.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1320-1324

Elsevier

Access to resources Recommend Favorite

The role of neoadjuvant or adjuvant chemotherapy for invasive bladder cancer - a prospective study

By Pavone-Macaluso M.   Hall R.R.   Hirao Y.   Kamidono S.   Miyanaga N.   de Mulder P.H.M.   Naito S.   Shipley W.U.   Tsushima T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 4, Iss. 4, 1998-07 ,pp. : 154-167

Elsevier

Access to resources Recommend Favorite

A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer

By              

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 855-859

Spandidos Publications

Access to resources Recommend Favorite

Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer

By                              

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 15-21

Spandidos Publications

Access to resources Recommend Favorite